3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
Gastrointestinal
232
Gynecologic
93
Thoracic
53
CNS
47
Breast
28
Other solid neoplasm
20
Tumor-Agnostic
18
Sarcoma
12
Head & Neck
12
Genitourinary
12
Dermatologic
11
Endocrine
3
NET
1
Myeloid
1
Lymphoid
1
Interventions
venetoclax
309
Cyclophosphamide
233
Cytarabine
200
Azacitidine
192
fludarabine
182
Specimen Handling
135
Biopsy
103
fludarabine phosphate
97
Methotrexate
82
Rituximab
80
Daunorubicin
79
Dexamethasone
76
Vincristine
70
Whole-Body Irradiation
65
Mycophenolic Acid
60
Decitabine
57
Tacrolimus
55
ibrutinib
52
Etoposide
52
blinatumomab
51
obinutuzumab
50
Granulocyte Colony-Stimulating Factor
50
Busulfan
50
Prednisone
48
Melphalan
48
acalabrutinib
47
Injections
47
Stem Cell Transplantation
45
Magnetic Resonance Spectroscopy
43
Idarubicin
43
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Bevacizumab
×
Other hematologic neoplasm
×
1 year
×
Clear all
No trials found.